Phase 4
Completed N=25
A Smoking Cessation Intervention for Yale Dining Employees
Source: ClinicalTrials.gov NCT02562521 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Apr 2018
Primary outcomePrimary: Number of Participants With a Smoking Quit Attempt in the Prior Six Weeks — 10; 1 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to evaluate a smoking cessation program for employees at the Yale University dining hall. Two pilot dining halls and six paired dining halls (3 test and 3 control sites) will be offered a contingency management/pharmacotherapy smoking cessation intervention at the work site.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With a Smoking Quit Attempt in the Prior Six Weeks |
10; 1 | — |
| PRIMARY Number of Participants Who Quit Smoking for at Least 24 Hours in the Prior Six Weeks |
8; 1 | — |
| SECONDARY Number of Participants Who Quit Smoking at 2 Months |
2 | — |
| SECONDARY Number of Participants Who Quit Smoking at 3 Months |
1 | — |
| SECONDARY Number of People Who Quit Smoking at 4 Months |
4 | — |
| SECONDARY Number of People Who Quit Smoking at 5 Months |
2 | — |
| SECONDARY Number of People Who Quit Smoking at 6 Months |
1 | — |
| SECONDARY Wisconsin Predicting Patient's Relapse Questionnaire |
4.80 | — |
| SECONDARY Wisconsin Predicting Patient's Relapse Questionnaire |
4.80 | — |
Eligibility Criteria
Inclusion Criteria
- Current smoker
- Interested in receiving treatment for quitting smoking.
- Employed for more than 20 hours per week by one of the 7 residential college dining halls selected for inclusion in this study.
- English speaker.
Exclusion Criteria
- None specified, other than failure to meet all inclusion criteria listed above.
Data sourced from ClinicalTrials.gov (NCT02562521). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.